25 May 2013
Keywords: study, suggests, tdm, at-risk, cellcept, patients, swiss
Article | 18 August 2008
Swiss drug major Roche presented data at the 22nd International Congress of the Transplantation Society, held in Sydney, Australia,
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 August 2008
24 May 2013
© 2013 thepharmaletter.com